KEGG   DRUG: Adintrevimab
Entry
D12389                      Drug                                   
Name
Adintrevimab (USAN/INN)
Formula
C6428H9932N1700O2032S40
Exact mass
144731.4934
Mol weight
144820.4105
Sequence
(Heavy chain)
EVQLVESGGG LVKPGGSLRL SCAASGFTFS SYYMNWVRQA PGKGLEWVSS ISEDGYSTYY
PDSLKGRFTI SRDSAKNSLY LQMNSLRADD TAVYYCARDF SGHTAWAGTG FEYWGQGTLV
TVSSASTKGP SVFPLAPSSK STSGGTAALG CLVKDYFPEP VTVSWNSGAL TSGVHTFPAV
LQSSGLYSLS SVVTVPSSSL GTQTYICNVN HKPSNTKVDK RVEPKSCDKT HTCPPCPAPE
LLGGPSVFLF PPKPKDTLMI SRTPEVTCVV VDVSHEDPEV KFNWYVDGVE VHNAKTKPRE
EQYNSTYRVV SVLTVLHQDW LNGKEYKCKV SNKALPAPIE KTISKAKGQP REPQVYTLPP
SREEMTKNQV SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPVLDSDGS FFLYSKLTVD
KSRWQQGNVF SCSVLHEALH AHYTQKSLSL SPGK
(Light chain)
QSVLTQPPSV SGAPGQRITI SCTGSSSNIG AGYDVHWYQQ LPGTAPKLLI YGSSSRNSGV
PDRFSGSKSG TSASLAITGL QAEDEADYYC QSYDSSLSVL YTFGTGTKVT VLGQPKAAPS
VTLFPPSSEE LQANKATLVC LISDFYPGAV TVAWKADSSP VKAGVETTTP SKQSNNKYAA
SSYLSLTPEQ WKSHRSYSCQ VTHEGSTVEK TVAPTECS
(Disulfide bridge: H22-H96, H151-H207, H227-L217, H233-H'233, H236-H'236, H268-H328, H374-H432, H'22-H'96, H'151-H'207, H'227-L'217, H'268-H'328, H'374-H'432, L22-L90, L140-L199, L'22-L'90, L'140-L'199)
  Type
Peptide
Class
Antiviral
 DG03174  Anti-SARS-CoV-2 agent
Efficacy
Antiviral
  Type
Monoclonal antibody
Comment
The prevention of SARS-CoV-2 infection and the subsequent disease, COVID-19
Target
SARS-CoV-2 spike glycoprotein [KO:K24152]
  Pathway
ko03230  Viral genome structure
ko05171  Coronavirus disease - COVID-19
Brite
Drug groups [BR:br08330]
 Antiviral
  DG03174  Anti-SARS-CoV-2 agent
   D12389  Adintrevimab
Antimicrobials [BR:br08307]
 Antivirals
  Entry, fusion or uncoating inhibitor
   Coronavirus spike protein
    D12389  Adintrevimab (USAN/INN)
Other DBs
CAS: 2516243-54-0
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system